Disease × agent pairs

NAFLD / MASH (Metabolic-Associated Steatohepatitis): candidate agents with evidence

8 agents linked to Metabolic Dysfunction-Associated Steatohepatitis by at least one registered trial or two publications, ranked by the OSMF evidence score. Not treatment advice.

Research Tracker › Pairs › NAFLD / MASH (Metabolic-Associated Steatohepatitis)
Open NAFLD / MASH (Metabolic-Associated Steatohepatitis) in the Repurposing ExplorerNAFLD / MASH (Metabolic-Associated Steatohepatitis) hub

Resmetirom

Drug · tier A · 4 trials (3 recruiting) · 15 publications · score 66.0

Atorvastatin

Drug · tier A · 0 trials (0 recruiting) · 6 publications · score 35.0

Genistein

Drug · tier A · 0 trials (0 recruiting) · 4 publications · score 34.0

Telmisartan

Drug · tier A · 0 trials (0 recruiting) · 3 publications · score 28.0

Valsartan

Drug · tier A · 0 trials (0 recruiting) · 4 publications · score 28.0

Hydrochlorothiazide

Drug · tier A · 0 trials (0 recruiting) · 3 publications · score 26.0

Angiotensin Ii

Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 24.0

Sodium Chloride

Drug · tier A · 1 trials (0 recruiting) · 1 publications · score 24.0

Research map, not treatment advice. Built 2026-10-07.